These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 35802286)

  • 21. Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases.
    Iyer S; Bhat I; Bangera Sheshappa M
    Mol Nutr Food Res; 2024 Jul; 68(13):e2300409. PubMed ID: 38487969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease.
    Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV
    Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Pharmacol Res; 2019 Aug; 146():104336. PubMed ID: 31271846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
    Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A
    Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
    Klose J; Griehl C; Roßner S; Schilling S
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association.
    Khezri MR; Esmaeili A; Ghasemnejad-Berenji M
    ACS Chem Neurosci; 2023 Nov; 14(21):3883-3893. PubMed ID: 37823531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.
    Hölscher C
    Neuropharmacology; 2018 Jul; 136(Pt B):251-259. PubMed ID: 29402504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.
    Kim SW; Lee JH; Kim B; Yang G; Kim JU
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging.
    Martínez-Coria H; Arrieta-Cruz I; Gutiérrez-Juárez R; López-Valdés HE
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.
    Naidu SAG; Wallace TC; Davies KJA; Naidu AS
    J Diet Suppl; 2023; 20(2):218-253. PubMed ID: 33977807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
    Goyal A; Solanki K; Verma A
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
    Choi DY; Choi H
    Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
    Khaafi F; Javadi B
    Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?
    Matos MJ
    Future Med Chem; 2021 Aug; 13(15):1301-1309. PubMed ID: 34137271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.